Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A

Journal of Medicine

Volumn 28, Issue 3-4, 1997, Pages 175-190

  Ueda, Masatsugu ^a   Ueki, Minoru ^a   Fujii, Hideji ^b   Yoshizawa, Keiko ^b   Nakajima, Motowo ^c  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b NIPPON KAYAKU CO LTD   (Japan)

^c CIBA GEIGY LTD   (Switzerland)

Author keywords

Aminopeptidase; Bestatin; Gelatinase A; Invasion; Uterine cervical carcinoma

Indexed keywords

AMINOPEPTIDASE; AMINOPEPTIDASE INHIBITOR; BESTATIN; ENZYME INHIBITOR; FIBRONECTIN; GELATINASE A; MATRIGEL; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CANCER INVASION; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

AMINOPEPTIDASES; ANTIBIOTICS, ANTINEOPLASTIC; CELL DIVISION; CELL MOVEMENT; FEMALE; GELATINASES; HUMANS; LEUCINE; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; PROTEASE INHIBITORS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0030668026     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Abe, F., Fujii, A., Yoshimura, K., Yugeta, E., Ishizuka, M. and Takeuchi, T. (1990).: Immunomodulatory and therapeutic characteristics of bestatin (ubenimex). Int. J. Immunother. 6: 203-209.
2. Albini, A., Iwamoto, Y., Kleinman, H.K., Martin, G.R., Aaronson, S.A., Kozlowski, J.M. and McEwan, R.N. (1987).: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47: 3239-3245.
3. Fidler, I.J., Gersten, D.M. and Hart, I.R. (1978).: The biology of cancer invasion and metastasis. Adv. Cancer Res. 28: 149-250.
4. Fujii, H., Nakajima, M., Saiki, I., Yoneda, J., Azuma, I. and Tsuruo, T. (1995).: Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD 13. Clin. Exp. Metastasis 13: 337-344.
5. Koizumi, M., Uede, T., Shijubo, N., Kudo, R., Hashimoto, M. and Kikuchi, K. (1988).: New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential. Cancer Res. 48: 6565-6572.
6. Liotta, L.A., Rao, C.V. and Barsky, S.H. (1983).: Tumor invasion and the extracellular matrix. Lab. Invest. 49: 636-649.
7. Liotta, L.A., Steeg, P.S. and Stetler-Stevenson, W.G. (1991).: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336.
8. Liotta, L.A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C.M. and Shafie, S. (1980).: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68.
9. Matrisian, L.M. (1990).: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6: 121-125.
10. McCarthy, J.B. and Furcht, L.T. (1984).: Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J. Cell Biol. 98: 1474-1480.
11. Nakajima, M., Welch, D.R., Belloni, P.N. and Nicolson, G.L. (1987).: Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clone of differing metastatic potentials. Cancer Res. 47: 4869-4876.
12. Nozawa, S., Udagawa, Y., Ohta, H., Kurihara, S. and Fishman, W.H. (1983).: Newly established uterine cervical cancer cell line (SKG-III) with Regan isoenzyme, human chorionic gonadotropin ß-subunit, and pregnancy-specific ß1-glycoprotein phenotypes. Cancer Res. 43: 1748-1760.
13. Ota, K. and Ogawa, N. (1990).: Randomized controlled study of chemoimmuno-therapy with bestatin of acute nonlymphocytic leukemia in adults. Biomed. Pharmacother. 44: 93-102.
14. Saiki, I., Fujii, H., Yoneda, J., Abe, F., Nakajima, M., Tsuruo, T. and Azuma, I. (1993).: Role of aminopeptidase N (CD13) in tumor-cell invasion and extra-cellular matrix degradation. Int. J. Cancer 54: 137-143.
15. Saiki, I., Murata, J., Watanabe, K., Fujii, H., Abe, F. and Azuma, I. (1989).: Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro. Jpn. J. Cancer Res. 80: 873-878.
16. Towbin, H., Staehelin, T. and Gordon, J. (1979).: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76: 4350-4354.
17. Ueda, M., Ueki, M. and Sugimoto, O. (1993).: Characterization of epidermal growth factor (EGF) receptor and biological effect of EGF on human uterine cervical adenocarcinoma cell line OMC-4. Hum. Cell 6: 218-225.
18. Ueda, M., Ueki, M., Yamada, T., Okamoto, Y., Maeda, T., Sugimoto, O. and Otsuki, Y. (1989).: Scatchard analysis of EGF receptor and effects of EGF on growth and TA-4 production of newly established uterine cervical cancer cell line (OMC-1). Hum. Cell 2: 401-410.
19. Umezawa, H., Aoyagi, T., Suda, H., Hamada, M. and Takeuchi, T. (1976).: Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J. Antibiot. 29: 97-99.
20. Woessner, F.J. (1991).: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154.
21. Yamada, T., Ueda, M., Otsuki, Y., Ueki, M. and Sugimoto, O. (1991).: Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol. Oncol. 40: 118-128.
22. Yoneda, J., Saiki, I., Fujii, H., Abe, F., Kojima, Y. and Azuma, I. (1992).: Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (Bestatin). Clin. Exp. Metastasis 10: 49-59.